Metahydroxylamine in the treatment of pregnant women with preeclampsia Study on the Effective Dose of Hypotension After Spinal Anesthesia

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200066420

Enrollment

Unknown

Registered

2022-12-05

Start date

2022-12-06

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preeclampsia

Interventions

Preeclamptic:metahydroxylamine

Eligibility

Sex/Gender

Female

Age

19 Years to 44 Years

Inclusion criteria

Inclusion criteria: Preeclamptic women undergoing cesarean section under combined spinal-epidural anesthesia

Exclusion criteria

Exclusion criteria: (1) ASA grade = grade III; (2) with contraindications to combined spinal-epidural anesthesia; (3) age 175cm; (5) weight 100kg; (6) Multiple pregnancy or gestational age < 28 weeks; (7) Fetal distress, abnormal fetal monitoring or fetal heart rate requiring immediate general anesthesia; (8) Past history of chronic hypertension.

Design outcomes

Primary

Measure	Time frame
blood pressure;	—

Countries

China

Contacts

Public ContactYu Cui

Chengdu Women and Children's Central Hospital

cuiyu19831001@163.com+86 18040308150

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026